This site is intended for healthcare professionals
Congress

EAACI Hybrid Congress 2021

The EAACI Hybrid Congress 2021 will be taking place on July 10-12. This year we will have the chance to explore yet a new format.

The EAACI Hybrid Congress 2021 will be taking place on July 10-12. This year we will have the chance to explore yet a new format, where a fantastic scientific programme will intertwine both digital and physical aspects of the meeting.

This year’s motto is “Harmonizing research and patient care in allergy, asthma and clinical immunology”. Although in recent years an effort in spreading clinical guidelines, position papers, and other recommendations for practicing allergy has been done by different societies and scientific organizations, the practice of allergy and research still differs across countries in Europe and other parts of the world. In this sense, EAACI wants to be present in this continuous effort, and our Congress will provide the setting to stir discussions on the best ways to tackle this challenge.

  • Event type:
    Congress
  • Date
    10 Jul 2021 - 12 Jul 2021
  • Location
Further information

Previous EAACI materials

EAACI Digital Congress 2020

Marcus Maurer and Alex Eggel present at the EAACI 2020 virtual symposium ‘Breakthrough in the understanding of the anti-IgE pathway in CSU’.

European Academy of Allergy and Clinical Immunology Congress 2019

The satellite symposium ‘Itching for expert insights? Interactive clinical cases to better manage your pruritus and urticaria patients’, was presented at the 2019 EAACI Congress which took place in Lisbon, Portugal.

EAACI 2018

Satellite symposium videos from EAACI 2018 'Global perspectives on chronic spontaneous urticaria management'. Our faculty answer audience questions from EAACI 2018 regarding antihistamine treatment for CSU. Our faculty answer audience questions from EAACI 2018 regarding CSU diagnostic testing and monitoring. View Marcus Maurer answering questions submitted by EAACI 2018 delegates during an interactive symposium. Our faculty answer audience questions from EAACI 2018 regarding other therapies for CSU and guideline updates. Our faculty answer audience questions FROM eaaci 2018 regarding third-line treatment for CSU. In this video recorded at EAACI 2018, Professor Masatoshi Abe discusses the first-line use of rupatadine in the treatment of CSU. Hear Professor Masatoshi Abe discusses recent Japanese data exploring the pathophysiology and management of patients with pruritus. Hear Professor Masatoshi Abe discuss the use of rupatadine in children for the treatment of chronic spontaneous urticaria. Watch part two of our case study where Marcus Maurer describes a diagnostic work-up, leading to a diagnosis of chronic urticaria. Watch part one of our case study to find out which CSU guidelines our panel and audience would use as chronic urticaria treatment. Discover our faculty from EAACI 2018 - speakers from Germany, Mexico, Israel and China and a global audience who were questioned throughout. Watch the final part of our case study where Marcus Maurer describes that even after a good response to third-line therapy, symptoms have returned. View Professor Marcus Maurer present an update on the recent guidelines for chronic urticaria and their effect on patients and doctors. Watch part three of our case study where Marcus Maurer updates us on a case study chronic urticaria treatment and symptom monitoring. View Professor Masatoshi Abe discuss platelet-activating factor (PAF) and its role. Hear Masatoshi Abe highlight recommendations for second-generation antihistamine use in CSU treatment. View the effect of up-dosing rupatadine in cold urticaria, CSU and on drowsiness, addressed by Professor Masatoshi Abe. Watch as Anthony Smith discusses 'What did the pivotal trials for omalizumab for CSU show?' - Dr Anthony Smith, Immunologist, SA.

EAACI 2017

Review a chronic urticaria focus from the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2017. Hear Torsten Zuberbier discuss whether second-generation antihistamines can be up-dosed to treat urticaria. Hear Torsten Zuberbier discuss whether second-generation antihistamines can be combined to treat urticaria. Hear Torsten Zuberbier discuss the advantages of using second-generation antihistamines for the treatment of urticaria.

EAACI 2016

The European Academy of Allergy and Clinical Immunology Congress 2016 was held in Vienna, Austria and provided a platform to share ideas with medical peers. Review congress highlights from EAACI 2016 presented by Dr Marta Ferrer and Prof Martin Metz discussing patient perspectives, current case studies and more. Further congress highlights from EAACI 2016 presented by Dr Ferrer and Prof Metz discussing basic research, including basophil reactivity and IgE levels. Additional congress highlights from EAACI 2016 presented by Dr Ferrer and Prof Metz discussing treatment with a focus on the use of omalizumab in CSU.